CY1120669T1 - Συνδυαστικη θεραπεια για αγωγη σκληρυνσης κατα πλακας - Google Patents

Συνδυαστικη θεραπεια για αγωγη σκληρυνσης κατα πλακας

Info

Publication number
CY1120669T1
CY1120669T1 CY181100679T CY181100679T CY1120669T1 CY 1120669 T1 CY1120669 T1 CY 1120669T1 CY 181100679 T CY181100679 T CY 181100679T CY 181100679 T CY181100679 T CY 181100679T CY 1120669 T1 CY1120669 T1 CY 1120669T1
Authority
CY
Cyprus
Prior art keywords
treatment
combination
lacinimod
teriflunomide
fingolimod
Prior art date
Application number
CY181100679T
Other languages
Greek (el)
English (en)
Inventor
Theis Terwey
Roland Rupp
Peder M Andersen
Original Assignee
Fwp Ip Aps
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP12179232.9A external-priority patent/EP2692343A1/en
Application filed by Fwp Ip Aps filed Critical Fwp Ip Aps
Publication of CY1120669T1 publication Critical patent/CY1120669T1/el

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CY181100679T 2012-08-03 2018-06-29 Συνδυαστικη θεραπεια για αγωγη σκληρυνσης κατα πλακας CY1120669T1 (el)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP12179232.9A EP2692343A1 (en) 2012-08-03 2012-08-03 Combination therapy for treatment of multiple sclerosis
US201261712008P 2012-10-10 2012-10-10
EP12187939.9A EP2692344A1 (en) 2012-08-03 2012-10-10 Combination therapy for treatment of Multiple sclerosis
EP13745073.0A EP2879672B1 (en) 2012-08-03 2013-08-02 Combination therapy for treatment of multiple sclerosis
PCT/EP2013/066285 WO2014020156A1 (en) 2012-08-03 2013-08-02 Combination therapy for treatment of multiple sclerosis

Publications (1)

Publication Number Publication Date
CY1120669T1 true CY1120669T1 (el) 2019-12-11

Family

ID=68771308

Family Applications (1)

Application Number Title Priority Date Filing Date
CY181100679T CY1120669T1 (el) 2012-08-03 2018-06-29 Συνδυαστικη θεραπεια για αγωγη σκληρυνσης κατα πλακας

Country Status (2)

Country Link
JP (2) JP6884841B2 (ja)
CY (1) CY1120669T1 (ja)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080299196A1 (en) * 2005-10-07 2008-12-04 Aditech Pharma Ab Controlled Release Pharmaceutical Compositions Comprising a Fumaric Acid Ester

Also Published As

Publication number Publication date
JP2021121603A (ja) 2021-08-26
JP6884841B2 (ja) 2021-06-09
JP2020037581A (ja) 2020-03-12

Similar Documents

Publication Publication Date Title
EA201590166A1 (ru) Комбинированная терапия для лечения рассеянного склероза
CY1119490T1 (el) Παραγωγα πυραζολοπυρρολιδινης και η χρηση τους στην θεραπεια νοσηματων
MX2020008258A (es) Formulaciones pediátricas de niraparib y métodos de tratamiento pediátricos.
CO7101246A2 (es) Compuesto de carbamato y preparación y uso de los mismos
CY1117440T1 (el) Συτηκτα παραγωγα ιμιδαζολης ως αναστολεις toy ido
MX2019012884A (es) Terapia de combinacion.
BR112012009376A2 (pt) composição farmacêutica, forma de dosagem farmacêutica, processo para a sua preparação, métodos de tratamento e seu uso
PE20142319A1 (es) Tratamiento de esclerosis multiple con combinacion de laquinimod y acetato de glatiramero
MX2014002171A (es) Tratamientos de combinacion para hepatitis c.
BR112016012506A8 (pt) combinações farmacêuticas, seus usos, e uso de um portador de dados
PE20150161A1 (es) Uso de laquinimod de dosis alta para el tratamiento de esclerosis multiple
NZ630589A (en) Methods of treating alzheimer’s disease and pharmaceutical compositions thereof
BR112012023139A2 (pt) composição farmacêutica para a prevenção ou o tratamento de doença do fígado gordo não alcóolico e o método para a prevenção ou tratamento de doença do fígado gordo não alcóolico usando a mesma.
ECSP12011962A (es) Tratamientos para trastornos gastrointestinales
BR112015010396A2 (pt) terapia de combinação
EA201491479A1 (ru) Производные лупановых тритерпеноидов и их фармацевтическое применение
AR096892A1 (es) Una combinación farmacéutica para el tratamiento del melanoma
EA201590697A1 (ru) Производные кетамина
AR089862A1 (es) USO DE LAQUINIMOD PARA EL TRATAMIENTO DE PACIENTES CON ENFERMEDAD DE CROHN EN QUIENES FRACASO UNA TERAPIA ANTI-FACTOR DE NECROSIS TUMORAL a (ANTI-TNFa) DE PRIMERA LINEA
CY1122899T1 (el) Υδατικη συσταση περιλαμβανουσα παρακεταμολη και ιβουπροφαινη
RU2017120184A (ru) Лекарства для замедления течения болезни паркинсона
BR112015019802A2 (pt) formulações farmacêuticas de nitrito e usos das mesmas
MX2022015629A (es) Uso de vibegron para tratar vejiga sobreactiva.
BR112012020377A8 (pt) utilização de um ou mais selecionado do grupo constituído por um composto da fórmula (i), uma mistura racêmica-diastereomérica e um isômero óptico do referido composto, e um sal farmaceuticamente aceitável e uma pródroga do mesmo, método, composição farmacêutica e kit para tratamento de caquexia e embalagem comercial
BR112019002945A2 (pt) terapia de combinação para o tratamento de câncer pancreático